UPM Biomedicals Launches FibGel™: A Breakthrough Injectable Nanocellulose Hydrogel for Medical Devices
Helsinki, Finland — 24 October 2024. UPM Biomedicals, the forerunner in biotechnology, has recently launched FibGel™, the world's first injectable nanocellulose hydrogel designed for medical devices. This novel, wood-based gel exhibits remarkable biocompatibility, effectively bridging gaps in current healthcare technologies aimed at improving patient outcomes.
FibGel™ enables safe and minimally invasive procedures, making it ideal for use in permanent implants. The development of this innovative hydrogel represents a significant stride forward in medical innovations, paving the way for a new generation of medical implants that are not only effective but also promote patient safety.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.